In 2011, the search for the physiological function of MT2 has become even more interesting by the observation that the administration of erythropoietin (EPO) fails to correct the microcytic anemia present in Tmprss6-mutated mice [10]. This evidence concerns the gene TMPRSS6 and microcytic anemia.